Literature DB >> 2419590

Rubella virus antigens: localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies.

K Y Green, P H Dorsett.   

Abstract

Monoclonal antibodies (MAbs) against the rubella virion were used to locate epitopes involved in hemagglutination and neutralization. The MAbs exhibiting high-level hemagglutination-inhibiting activity were shown by Western blot analysis to be specific for the E1 polypeptide; this is consistent with the presence of the hemagglutinin on the E1 polypeptide. Some of the E1-specific MAbs also neutralized viral infectivity. However, hemagglutination-inhibiting activity and neutralizing activity did not always correlate. Three distinct functional epitopes were identified on the E1 polypeptide by competition analyses: one which reacted with MAbs with high-level hemagglutination-inhibiting activity and with neutralizing activity, one which reacted with MAbs with low-level hemagglutination-inhibiting activity and with neutralizing activity, and one which reacted with MAbs with only hemagglutination-inhibiting activity. A MAb specific for the E2 polypeptide exhibited neutralizing activity. This E2-specific MAb and two E1-specific MAbs with neutralizing activity were capable of precipitating intact virus which indicates that at least three epitopes involved in neutralization are accessible on the surface of the virion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419590      PMCID: PMC252819     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  [Rubella virus. I. Morphology and structural proteins].

Authors:  P Payment; D Ajdukovic; V Pavilanis
Journal:  Can J Microbiol       Date:  1975-05       Impact factor: 2.419

2.  Efficacy and immune response to rubella subunits vaccines.

Authors:  R Cappel; F De Cuyper
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

3.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

4.  Structural proteins and subunits of rubella virus.

Authors:  A Vaheri; T Hovi
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

5.  Physical and immunologic properties of rubella antigens.

Authors:  N J Schmidt; E H Lennette; P S Gee; J Dennis
Journal:  J Immunol       Date:  1968-04       Impact factor: 5.422

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  A better cell line for making hybridomas secreting specific antibodies.

Authors:  M Shulman; C D Wilde; G Köhler
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

8.  Detailed immunologic analysis of the structural polypeptides of rubella virus using monoclonal antibodies.

Authors:  M N Waxham; J S Wolinsky
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

9.  A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells.

Authors:  M L Gefter; D H Margulies; M D Scharff
Journal:  Somatic Cell Genet       Date:  1977-03

10.  Use of the avidin-biotin complex for the localization of actin and myosin with fluorescence microscopy.

Authors:  M H Heggeness; J F Ash
Journal:  J Cell Biol       Date:  1977-06       Impact factor: 10.539

View more
  31 in total

1.  Evaluation of antibodies against a rubella virus neutralizing domain for determination of immune status.

Authors:  P Cordoba; A Lanoel; S Grutadauria; M Zapata
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

Review 2.  Rubella virus replication and links to teratogenicity.

Authors:  J Y Lee; D S Bowden
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

3.  Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C.

Authors:  H H Chaye; C A Mauracher; A J Tingle; S Gillam
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

4.  Role of N-linked oligosaccharides in processing and intracellular transport of E2 glycoprotein of rubella virus.

Authors:  Z Qiu; T C Hobman; H L McDonald; N O Seto; S Gillam
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

5.  Detection of rubella virus-specific immunoglobulin G (IgG), IgM, and IgA antibodies by immunoblot assays.

Authors:  T Zhang; C A Mauracher; L A Mitchell; A J Tingle
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

6.  Presence of a neutralizing domain in isolates of rubella virus in Cordoba, Argentina.

Authors:  P Cordoba; S L Grutadauria; C Cuffini; M T Zapata
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

7.  Anti-idiotypic antibodies to rubella virus.

Authors:  A Nath; B Slagle; J S Wolinsky
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

Review 8.  Molecular and Structural Insights into the Life Cycle of Rubella Virus.

Authors:  Pratyush Kumar Das; Margaret Kielian
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

9.  Expression and characterization of virus-like particles containing rubella virus structural proteins.

Authors:  Z Qiu; D Ou; T C Hobman; S Gillam
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  Human T- and B-cell epitopes of E1 glycoprotein of rubella virus.

Authors:  H Chaye; D Ou; P Chong; S Gillam
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.